LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 45.61 | 770.25 | 1380 | 5813 | 0.2374 | 0.2214 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 45.61 | 770.25 | 1124 | 5813 | 0.1934 | 0.1384 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 47.83 | 770.25 | 1320 | 6223 | 0.2121 | 0.1957 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 47.83 | 770.25 | 1148 | 6223 | 0.1845 | 0.1416 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 50.05 | 770.25 | 1428 | 6629 | 0.2154 | 0.2199 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 50.05 | 770.25 | 1214 | 6629 | 0.1831 | 0.1578 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 52.27 | 770.25 | 1345 | 7058 | 0.1905 | 0.1906 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 52.27 | 770.25 | 1151 | 7058 | 0.1631 | 0.1339 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 54.49 | 770.25 | 1517 | 7555 | 0.2008 | 0.2285 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 54.49 | 770.25 | 1279 | 7555 | 0.1693 | 0.1664 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 56.71 | 770.25 | 1446 | 8001 | 0.1807 | 0.2050 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 56.71 | 770.25 | 1359 | 8001 | 0.1698 | 0.1831 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 58.94 | 770.25 | 1525 | 8444 | 0.1806 | 0.2186 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 58.94 | 770.25 | 1330 | 8444 | 0.1575 | 0.1713 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 61.16 | 770.25 | 1561 | 8892 | 0.1756 | 0.2216 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 61.16 | 770.25 | 1252 | 8892 | 0.1408 | 0.1476 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 63.39 | 770.25 | 1592 | 9326 | 0.1707 | 0.2236 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 63.39 | 770.25 | 1443 | 9326 | 0.1547 | 0.1906 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 65.61 | 770.25 | 1509 | 9736 | 0.1550 | 0.2017 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 65.61 | 770.25 | 1390 | 9736 | 0.1428 | 0.1750 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 67.83 | 770.25 | 1571 | 10078 | 0.1559 | 0.2118 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 67.83 | 770.25 | 1372 | 10078 | 0.1361 | 0.1684 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 70.05 | 770.25 | 1667 | 10413 | 0.1601 | 0.2281 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 70.05 | 770.25 | 1678 | 10413 | 0.1611 | 0.2303 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 72.27 | 770.25 | 1724 | 10730 | 0.1607 | 0.2362 | MN20160304_L02 | E08 |